Dennis A Revicki

Summary

Affiliation: MEDTAP International
Country: USA

Publications

  1. ncbi Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP Institute at UBC, Bethesda, MD 20814, USA
    Headache 46:240-52. 2006
  2. ncbi Interpreting and reporting results based on patient-reported outcomes
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Value Health 10:S116-24. 2007
  3. ncbi Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial
    Richard Shikiar
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Dermatolog Treat 18:25-31. 2007
  4. ncbi Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Affect Disord 86:183-93. 2005
  5. ncbi Imputing physical health status scores missing owing to mortality: results of a simulation comparing multiple techniques
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International, Bethesda, Maryland 20814, USA
    Med Care 39:61-71. 2001
  6. ncbi Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
    D A Revicki
    MEDTAP International, Bethesda, Maryland, USA
    Qual Life Res 9:887-900. 2000
  7. ncbi Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International Inc, Bethesda, MD 20814, USA
    Curr Opin Investig Drugs 2:110-7. 2001
  8. ncbi Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes
    Dennis A Revicki
    Center for Outcomes Research, MEDTAP International, Bethesda, MD 20814, USA
    J Clin Psychiatry 64:288-94. 2003
  9. ncbi Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International, Inc, Bethesda, MD 20814, USA
    Aliment Pharmacol Ther 18:141-50. 2003
  10. ncbi Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP International, Inc, Bethesda, Maryland, USA
    Health Qual Life Outcomes 1:73. 2003

Detail Information

Publications112 found, 100 shown here

  1. ncbi Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP Institute at UBC, Bethesda, MD 20814, USA
    Headache 46:240-52. 2006
    ..01). CONCLUSION: The PPMQ-R is a reliable and valid measure of patient satisfaction with acute migraine treatment in women with frequent migraine attacks...
  2. ncbi Interpreting and reporting results based on patient-reported outcomes
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Value Health 10:S116-24. 2007
    ..Clinical trial reports need to be comprehensive, clear, and sufficient to enable any reader to understand the methods, PRO measures, statistical analysis, and results...
  3. ncbi Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial
    Richard Shikiar
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Dermatolog Treat 18:25-31. 2007
    ..Psoriasis substantially impairs the health-related quality of life (HRQOL) of patients, and a comprehensive evaluation of treatment includes HRQOL measures...
  4. ncbi Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Affect Disord 86:183-93. 2005
    ..The clinical, quality of life (QOL), and medical cost outcomes of treatment with divalproex were compared with lithium in patients with bipolar I disorder over 1 year...
  5. ncbi Imputing physical health status scores missing owing to mortality: results of a simulation comparing multiple techniques
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International, Bethesda, Maryland 20814, USA
    Med Care 39:61-71. 2001
    ..Having missing data complicates the statistical analysis of health-related quality-of-life (HRQOL) data and, depending on the extent and nature of missing data, can introduce significant bias in treatment comparisons...
  6. ncbi Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
    D A Revicki
    MEDTAP International, Bethesda, Maryland, USA
    Qual Life Res 9:887-900. 2000
    ....
  7. ncbi Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International Inc, Bethesda, MD 20814, USA
    Curr Opin Investig Drugs 2:110-7. 2001
    ..There is insufficient published data on pharmacoeconomic outcomes for sertindole, quetiapine and ziprasidone to make any conclusions about their cost-effectiveness in treating schizophrenia...
  8. ncbi Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes
    Dennis A Revicki
    Center for Outcomes Research, MEDTAP International, Bethesda, MD 20814, USA
    J Clin Psychiatry 64:288-94. 2003
    ..This study compares the clinical, health-related quality of life (HRQL), and economic outcomes of divalproex and olanzapine in the treatment of acute mania associated with bipolar disorder...
  9. ncbi Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International, Inc, Bethesda, MD 20814, USA
    Aliment Pharmacol Ther 18:141-50. 2003
    ..Patient-based symptom assessments are necessary to evaluate the effectiveness of medical treatments for gastroparesis...
  10. ncbi Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP International, Inc, Bethesda, Maryland, USA
    Health Qual Life Outcomes 1:73. 2003
    ....
  11. ncbi Patient assessment of treatment satisfaction: methods and practical issues
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Gut 53:iv40-4. 2004
    ..Treatment satisfaction may be important for differentiating among GORD treatments, and for monitoring patient outcomes in clinical practice...
  12. ncbi Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP International, Inc, Bethesda, MD 20814, USA
    Qual Life Res 13:833-44. 2004
    ..Patient-rated symptom assessments are needed for evaluating the effectiveness of medical treatments and for monitoring outcomes in gastroparesis...
  13. ncbi Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders
    Dennis A Revicki
    Center for Health Outcome Research, MEDTAP International, Bethesda, MD 20814, USA
    Clin Gastroenterol Hepatol 2:769-77. 2004
    ..This study evaluates responsiveness of the Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) in gastroesophageal reflux disease (GERD) and dyspepsia...
  14. ncbi Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3
    D A Revicki
    MEDTAP International Inc, Bethesda, MD, USA
    Antivir Ther 4:35-44. 1999
    ..This double-blind study evaluated zalcitabine or saquinavir monotherapy and combination saquinavir plus zalcitabine therapy on HROL of human immunodeficiency virus (HIV)-infected adults...
  15. ncbi Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International, Bethesda, MD 20814, USA
    Aliment Pharmacol Ther 13:1621-30. 1999
    ..We evaluated the association between complete resolution of heartburn symptoms and functioning and well-being in three samples of patients with GERD...
  16. ncbi Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International, Bethesda, Maryland, USA
    Pharmacoeconomics 15:423-34. 1999
    ....
  17. ncbi Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International, Bethesda, Maryland 20814, USA
    J Clin Psychiatry 60:7-11; discussion 28-30. 1999
    ..Mirror-image studies and clinical decision analysis models provide further support for these findings...
  18. ncbi Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease
    D A Revicki
    Center for Health Outcomes Research, MEDTAP International, Bethesda MD 20814, USA
    Dig Dis 16:284-91. 1998
    ....
  19. ncbi Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index
    D A Revicki
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    Chest 114:998-1007. 1998
    ..To develop and evaluate a brief, easy-to-administer symptom assessment scale for use as a preference-based outcome measure in clinical trials and cost-effectiveness studies in asthma...
  20. ncbi Work-related stress and psychological distress in emergency medical technicians
    D A Revicki
    MEDTAP International, Arlington, Virginia 22201, USA
    J Occup Health Psychol 1:391-6. 1996
    ..Work-related stress was strongly related to psychological distress. Changes in work-related stress were significantly related to changes in psychological distress. Findings support the work-related stress, psychological distress model...
  21. ncbi Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications
    D A Revicki
    MEDTAP International, Bethesda, MD 20814, USA
    J Affect Disord 48:25-36. 1998
    ..We compared patient utilities for hypothetical depression-related and current health states and to examine differences in utilities by patient demographic and clinical characteristics...
  22. ncbi Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia
    D A Revicki
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    Schizophr Res 35:S101-9. 1999
    ....
  23. ncbi The new atypical antipsychotics: a review of pharmacoeconomic studies
    D A Revicki
    MEDTAP International, Inc, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Expert Opin Pharmacother 1:249-60. 2000
    ..There is too little data on pharmacoeconomic outcomes for sertindole and quetiapine to make any conclusions about their cost-effectiveness in treating schizophrenia...
  24. ncbi Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group
    D A Revicki
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    AIDS 13:851-8. 1999
    ....
  25. ncbi Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index
    D A Revicki
    Center for Health Outcome Research, MEDTAP International, Inc, Bethesda, MD 20814, USA
    Qual Life Res 7:693-702. 1998
    ..The modest reproducibility reflects the day to day variability of rhinitis. The RSUI may be a useful patient outcome for clinical trials and for cost-effectiveness studies comparing medical treatments for rhinitis...
  26. ncbi Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement
    Roger E Meyer
    Best Practice Project Management, Inc, PO Box 30219, Bethesda, MD 20824, USA
    J Clin Psychiatry 71:e1-e21. 2010
    ..To address issues concerning potential treatment-emergent "suicidality," a consensus conference was convened March 23-24, 2009...
  27. ncbi Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland, USA
    Health Qual Life Outcomes 6:75. 2008
    ..To evaluate the impact of adalimumab on health-related quality of life (HRQOL) for patients with moderate to severe plaque psoriasis...
  28. ncbi The patient experience of depression and remission: focus group results
    Lori Frank
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland, USA biosource com
    J Nerv Ment Dis 195:647-54. 2007
    ..Results suggest that new measures of treatment outcome should encompass irritability, anger, and ability to cope with life stressors...
  29. ncbi Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report
    Louis S Matza
    MEDTAP International, Inc, Center for Health Outcomes Research, Bethesda, MD 20814, USA
    Qual Life Res 14:735-47. 2005
    ..03). Results suggest that parent SG interviews are a feasible and useful method for obtaining utility scores that can be used in cost-effectiveness models of ADHD treatment...
  30. ncbi Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis
    Dennis A Revicki
    Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 9:36. 2011
    ..We evaluated the psychometric characteristics of the Short Form 36 (SF-36) Health Survey and the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue subscale in patients with ankylosing spondylitis (AS)...
  31. ncbi Development and psychometric evaluation of 2 age-stratified versions of the Pediatric GERD Symptom and Quality of Life Questionnaire
    Leah Kleinman
    United BioSource Corporation, Bethesda, MD 20814, USA
    J Pediatr Gastroenterol Nutr 52:514-22. 2011
    ..These include the PGSQ-Cp (for children ages 2 to 8 years, parent/caregiver report) and the PGSQ-A (for adolescents ages 9-17 years). The objective of the present study was to develop and evaluate PGSQ measurement properties...
  32. ncbi Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials
    Richard Shikiar
    Center for Health Outcomes Research, MEDTAP International, Inc, Seattle, WA USA
    Health Qual Life Outcomes 1:53. 2003
    ..Patient reported measures of psoriasis-related functionality and health-related quality of life and of psoriasis-related symptom assessments were included as part of the trials...
  33. ncbi Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Bethesda, MD 20814, USA
    J Dermatolog Treat 18:341-50. 2007
    ..The effect of adalimumab on patient-reported outcomes (PROs) was evaluated in patients with moderate to severe psoriasis during the initial 16-week, double-blind period of a 52-week, Phase III, multicenter trial...
  34. ncbi Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients
    Margaret K Vernon
    United BioSource Corporation, Bethesda, MD 20814, USA
    Schizophr Res 118:271-8. 2010
    ..A 1-point change on the MSQ may be considered clinically meaningful...
  35. ncbi Assessment of quality of life enjoyment and satisfaction questionnaire-short form responder thresholds in generalized anxiety disorder and bipolar disorder studies
    Kathleen W Wyrwich
    United BioSource Corporation, Bethesda, Maryland 20814, USA
    Int Clin Psychopharmacol 26:121-9. 2011
    ..A responder definition needs to be investigated within each condition or disease using appropriate anchors, and may not be generalizable from one condition or disease to another...
  36. ncbi The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy
    Leah Kleinman
    Outcomes Research, United BioSource Corporation, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 21:1255-66. 2012
    ..To develop a patient-reported outcome instrument for measuring anemia symptoms and their impact in patients with chemotherapy-induced anemia (CIA)...
  37. ncbi Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia
    Louis S Matza
    Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Psychiatry Res 200:835-42. 2012
    ..Findings indicate that clinicians usually report multiple reasons for discontinuation, rather than a single reason for each patient...
  38. ncbi A cost-effectiveness clinical decision analysis model for treatment of Schizophrenia
    Cynthia S Palmer
    Center for Organization and Delivery Studies, Agency for Health Care Policy and Research, Rockville, MD, USA
    Arch Med Res 33:572-80. 2002
    ..Olanzapine results in slightly improved patient outcomes and comparable costs compared with risperidone...
  39. ncbi Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Qual Life Res 18:783-91. 2009
    ..We predicted EuroQoL (EQ-5D) index scores from patient-reported outcomes measurement information system (PROMIS) global items and domain item banks...
  40. ncbi Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Dermatology 216:260-70. 2008
    ..However, the association between HRQOL outcomes and more substantial degrees of Psoriasis Area and Severity Index (PASI) response and physician and patient global ratings remains ill defined...
  41. ncbi Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: results from a randomized clinical trial
    Dennis A Revicki
    United BioSource Corporation, Bethesda, MD, USA
    Leuk Res 37:259-65. 2013
    ..05). Clinically important changes in HRQL from baseline were observed at weeks 12, 24, 36, and 48 among RBC-TI≥26 week responders in both treatment groups. Lenalidomide treatment may be effective in improving HRQL outcomes...
  42. ncbi Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation
    Louis S Matza
    Outcomes Research, United BioSource Corporation, Bethesda, MD
    Patient Prefer Adherence 6:521-32. 2012
    ....
  43. ncbi Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland 20814, USA
    Invest Ophthalmol Vis Sci 51:712-7. 2010
    ..To evaluate the psychometric characteristics of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in patients with age-related macular degeneration (AMD) who participated in two clinical trials...
  44. ncbi Patient-based utilities for bipolar disorder-related health states
    Dennis A Revicki
    Center for Health Outcomes Research, The MEDTAP Institute at United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Affect Disord 87:203-10. 2005
    ..This study estimated health state utilities for hypothetical bipolar-related health states and patient's current health from bipolar I patients...
  45. ncbi Development and psychometric analysis of the PROMIS pain behavior item bank
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Pain 146:158-69. 2009
    ..The PROMIS pain behavior item bank can be used to develop static short-form and dynamic measures of pain behavior for clinical studies...
  46. ncbi Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS)
    Robin F Pokrzywinski
    United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 7:98. 2009
    ..We developed and evaluated the psychometric performance of a patient-reported measure to assess the impact on sleep due to respiratory disease, the COPD and Asthma Sleep Impact Scale (CASIS)...
  47. ncbi Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration
    Peggy Orr
    Retina Division, Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Invest Ophthalmol Vis Sci 52:3354-9. 2011
    ..This study's objective was to evaluate such associations along with questions on restricted activity days...
  48. ncbi Understanding the relationships between health outcomes in generalized anxiety disorder clinical trials
    Kathleen W Wyrwich
    United BioSource Corporation, 7101 Wisconsin Ave Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 20:255-62. 2011
    ..This study tested the application of the Wilson-Cleary model to a patient population with generalized anxiety disorder (GAD) using longitudinal clinical trial data...
  49. ncbi Development of a clinician questionnaire and patient interview to assess reasons for antipsychotic discontinuation
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Psychiatry Res 189:463-8. 2011
    ..The RAD-Q and RAD-I appear to be useful instruments for assessing reasons for antipsychotic discontinuation and continuation. The next step is a psychometric evaluation of the measures in a larger sample...
  50. ncbi The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review
    Manishi Prasad
    MEDTAP International, Bethesda, MD 20814, USA
    Pharmacoeconomics 21:769-90. 2003
    ..Although there is evidence that treatment for GORD does improve symptoms and HR-QOL outcomes, further research is needed to more completely understand the value of medical therapy for GORD...
  51. ncbi Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder
    Anne M Rentz
    Center for Health Outcomes Research, MEDTAP International, Bethesda, MD 20814, USA
    Qual Life Res 14:719-34. 2005
    ..Study results indicate the CHQ-PF50 is reliable, valid, and responsive to change in ADHD symptoms, suggesting it may provide a means of assessing HRQL outcomes associated with treatments for ADHD...
  52. ncbi Responsiveness and minimal important differences for patient reported outcomes
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Health Qual Life Outcomes 4:70. 2006
    ..Responsiveness and MID must be demonstrated and documented for the particular study population, and these measurement characteristics are needed for PRO labeling and promotional claims...
  53. ncbi Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP Institute, 7101 Wisconsin Avenue, Bethesda, MD 20814, USA
    Arch Gen Psychiatry 62:868-75. 2005
    ..Few clinical trials have evaluated interventions for major depressive disorder in samples of low-income minority women, and little is known about the cost-effectiveness of depression interventions for this population...
  54. ncbi Practical and philosophical issues surrounding a national item bank: if we build it will they come?
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 16:167-74. 2007
    ....
  55. ncbi The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study
    Richard Shikiar
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 4:71. 2006
    ....
  56. ncbi Major symptom score utility index for patients with acute rhinosinusitis
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland 20814, USA
    Am J Rhinol Allergy 25:99-106. 2011
    ..e., validity and responsiveness) of the MSS Utility Index (MSSUI)...
  57. ncbi Development and validation of a patient-report measure of fatigue associated with depression
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, United States
    J Affect Disord 134:294-303. 2011
    ..Thus, the purpose of the current study was to develop and validate a patient-reported outcome measure designed to assess depression-related fatigue and its impact...
  58. ncbi The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder
    Louis S Matza
    MEDTAP International, Inc, Bethesda, Maryland, USA
    J Dev Behav Pediatr 25:166-74. 2004
    ..The findings suggest that HRQL instruments can add important information to efficacy measures in clinical trials of ADHD treatment...
  59. ncbi Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants
    Kathleen W Wyrwich
    United BioSource Corporation, Bethesda, MD 20814, USA
    Qual Life Res 19:551-64. 2010
    ..Valid instruments are needed to assess important patient-reported outcomes (PROs) in erosive esophagitis (EE)...
  60. ncbi Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review
    Louis S Matza
    The MEDTAP Institute at UBC, Bethesda, Maryland 20814, USA
    CNS Drugs 19:499-515. 2005
    ..Firm conclusions regarding the comparison between olanzapine and ziprasidone require additional published trials on ziprasidone, particularly in direct comparison with olanzapine...
  61. ncbi The impact of diabetic retinopathy: perspectives from patient focus groups
    Karin S Coyne
    MEDTAP International, Bethesda, MD 20814, USA
    Fam Pract 21:447-53. 2004
    ..Diabetic retinopathy (DR) affects 50-85% of people with diabetes and may result in visual impairment or blindness...
  62. ncbi Humanistic and economic burden of generalized anxiety disorder in North America and Europe
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    J Affect Disord 140:103-12. 2012
    ..To review the humanistic and economic burden of generalized anxiety disorder (GAD)...
  63. ncbi Assessing health-related quality of life in generalized anxiety disorder using the Quality Of Life Enjoyment and Satisfaction Questionnaire
    Kathleen Wyrwich
    United BioSource Corporation, Bethesda, Maryland 20814, USA
    Int Clin Psychopharmacol 24:289-95. 2009
    ..02). This analysis shows the overall reliability, validity, and responsiveness of the Q-LES-Q (SF) as a measure of overall quality of life and satisfaction in patients with GAD...
  64. ncbi Validation issues in questionnaires for diagnosis and monitoring of gastroesophageal reflux disease in children
    Leah Kleinman
    United BioSource Corporation, Center for Health Outcomes Research, Seattle, WA 98121, USA
    Curr Gastroenterol Rep 8:230-6. 2006
    ..Measures of pediatric GERD symptoms include the GERQ, GERQ-R, and GSQ. These measures have advantages and disadvantages with regard to feasibility, reliability, and validity. Questionnaires are lacking for children older than 4 years...
  65. ncbi Psychometric properties of the Personal and Social Performance scale (PSP) among individuals with schizophrenia living in the community
    Ariane K Kawata
    United BioSource Corporation, Center for Health Outcomes Research, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 17:1247-56. 2008
    ..The Personal and Social Performance scale (PSP; Morosini et al. Acta Psychiatrica Scandinavica 101(4):323-329, 2000) is a clinical tool assessing social functioning in rehabilitation settings...
  66. ncbi Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment
    Louis S Matza
    Center for Health Outcomes Research at UBC, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Schizophr Bull 32:666-78. 2006
    ..When creating new functional outcomes measures for assessment of patients with schizophrenia, responsiveness to change in CIAS should be evaluated as part of the development and validation process...
  67. ncbi Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS)
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland 20814, USA
    J Rheumatol 35:1346-53. 2008
    ..To evaluate the effect of adalimumab on pain, fatigue, and stiffness in patients with active ankylosing spondylitis (AS)...
  68. ncbi Evaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries
    Emuella M Flood
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, United States
    Health Qual Life Outcomes 4:51. 2006
    ..This study evaluated ASUI preference weights in Europe to determine whether the multi-attribute utility function, based on preferences from a US population, is generalizable across countries...
  69. ncbi Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy
    Ariane K Kawata
    United BioSource Corporation, Bethesda, Maryland 20814, USA
    Clin Drug Investig 29:215-29. 2009
    ..This study evaluated the reliability, validity and responsiveness of the FAST. The minimal important difference (MID) of the FAST was also examined...
  70. ncbi Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 16:717-23. 2007
    ..The PRO Evidence Dossier may also be helpful to industry and academic researchers in identifying further information that will need to be developed to support the clinical development program and the PRO endpoints...
  71. ncbi Depression and health-related quality of life for low-income African-American women in the U.S
    Lori B Frank
    Center for Health Outcomes Research, The MEDTAP Institute at UBC, 7101 Bethesda, MD, USA
    Qual Life Res 14:2293-301. 2005
    ..Results indicate the substantial HRQL impact of depression among low-income young African-American women with depression...
  72. ncbi The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument
    Leah Kleinman
    Center for Health Outcomes Research, United BioSource Corporation, Seattle, Washington 98121, USA
    Clin Gastroenterol Hepatol 4:588-96. 2006
    ..We revised the Infant Gastroesophageal Reflux Questionnaire (I-GERQ) on the basis of information from parents of infants with GERD and physicians and subjected it to a psychometric evaluation...
  73. ncbi Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients
    Margaret K Vernon
    United BioSource Corporation, Center for Health Outcomes Research, Bethesda, Maryland 20814, USA
    J Pain Symptom Manage 36:54-68. 2008
    ..The DSIS demonstrated robust test-retest reliability, good construct and discriminant validity and responsiveness in painful DPN and PHN patients. A 1-2 point change on the DSIS might be interpreted as an important difference...
  74. ncbi Health-related quality of life and utilities in primary-care patients with generalized anxiety disorder
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 17:1285-94. 2008
    ..Generalized anxiety disorder (GAD) is prevalent and significantly impacts patient health-related quality of life (HRQL) and disability...
  75. ncbi Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS)
    Bryce B Reeve
    National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
    Med Care 45:S22-31. 2007
    ..The construction and evaluation of item banks to measure unidimensional constructs of health-related quality of life (HRQOL) is a fundamental objective of the Patient-Reported Outcomes Measurement Information System (PROMIS) project...
  76. ncbi Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials
    Dennis A Revicki
    Center for Health Outcomes Research, The MEDTAP Institute at United BioSource Corporation, Bethesda, Maryland 20814, USA. biosource.com
    Pharmacoeconomics 23:583-94. 2005
    ..HR-QOL outcome data may be useful in informing psychiatrists, patients and patient family members of the effects of treatment for bipolar disorder on patients' everyday lives, functioning and wellbeing...
  77. ncbi Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences
    Louis S Matza
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    Arch Gen Psychiatry 60:817-26. 2003
    ..The current study was conducted to increase understanding of atypical depression diagnosed using only the reversed vegetative symptoms of hypersomnia and hyperphagia...
  78. ncbi The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey
    Karin S Coyne
    MEDTAP International, Bethesda, MD 20814, USA
    Value Health 7:455-63. 2004
    ..Most attention to OAB's impact on health-related quality of life (HRQL), however, has focused on urge incontinence. The objective of this study was to evaluate the burden of OAB, specifically urinary urgency and frequency on HRQL...
  79. ncbi Evaluating effects of method of administration on Walking Impairment Questionnaire
    Karin S Coyne
    MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Vasc Surg 38:296-304. 2003
    ..Currently this questionnaire is validated for interviewer administration only. Since this can be burdensome in a large clinical trial, we examined the effects of alternative methods of administration on patient responses on the WIQ...
  80. ncbi Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review
    Mary Kay Margolis
    MEDTAP International, Inc, Bethesda, Maryland 20814, USA
    Pharmacoeconomics 20:791-812. 2002
    ....
  81. ncbi Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders
    A M Rentz
    MEDTAP International, Inc, Sindelfingen, Germany
    Qual Life Res 13:1737-49. 2004
    ....
  82. ncbi Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature
    A M Rentz
    Center for Health Outcomes Research, MEDTAP International, Inc, Bethesda, Maryland 20814, USA
    Pharmacoeconomics 19:349-63. 2001
    ..Future clinical trials of GI disorders should combine clinician assessments of outcomes and symptoms with patient-rated symptom and HR-QOL end-points...
  83. ncbi Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus
    K S Chan
    Center for Health Outcomes Research, MEDTAP International, Bethesda, MD 20814, USA
    Eval Health Prof 21:265-81. 1998
    ..To evaluate the relationship between laboratory markers of HIV, AIDS-defining events, study discontinuation, and summary scores from the MOS-HIV Health Survey...
  84. ncbi Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)
    A W Wu
    Department of Health Policy and Management, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD, USA
    Qual Life Res 6:481-93. 1997
    ..The interpretation of scores is facilitated by an explanation in terms meaningful to the intended audience. Research is needed to compare the MOS-HIV to other strategies for HRQoL assessment in early HIV disease...
  85. ncbi Reliability and validity of the social integration survey (SIS) in patients with schizophrenia
    Ariane K Kawata
    United BioSource Corporation, Center for Health Outcomes Research, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 17:123-35. 2008
    ..Schizophrenia-related impairments impact functional status and health-related quality of life. The Social Integration Survey (SIS) measures social functioning outcomes in schizophrenia from patient and informant perspectives...
  86. ncbi Development and content validity of a gastroparesis cardinal symptom index daily diary
    D A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Aliment Pharmacol Ther 30:670-80. 2009
    ..The Gastroparesis Cardinal Symptom Index (GCSI) is a patient-reported outcome for gastroparesis using a two-week recall period. To minimize potential patient recall effects, a daily diary version of the GCSI (GCSI-DD) was developed...
  87. ncbi Economics of atypical antipsychotics in bipolar disorder: a review of the literature
    Rachael L Fleurence
    United BioSource Corporation, Health Care Analytics Group, Bethesda, Maryland 20814, USA
    CNS Drugs 20:591-9. 2006
    ..A better understanding of the complex interplay between effectiveness, safety, quality of life, adherence and resource use should ultimately contribute to improving the treatment of bipolar disorder...
  88. ncbi Validation of the revised Patient Perception of Migraine Questionnaire (PPMQ-R): measuring satisfaction with acute migraine treatment in clinical trials
    M Kimel
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Cephalalgia 28:510-23. 2008
    ..All scales discriminated among migraine pain severity levels (all P < 0.001). The PPMQ-R has sufficient evidence of validity and reliability for measuring patient satisfaction, an important benchmark of quality and effective care...
  89. ncbi Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma
    Kimberly Niebauer
    Center for Health Outcomes Research, The MEDTAP Institute at United BioSource Corporation, Bethesda, Maryland 20814, USA
    Ann Allergy Asthma Immunol 96:316-26. 2006
    ..The meta-analysis findings demonstrate that omalizumab treatment provides QOL benefits in patients with moderate-to-severe allergic asthma...
  90. ncbi The economics of selective serotonin reuptake inhibitors in depression: a critical review
    L Frank
    MEDTAP International, Bethesda, Maryland 20814, USA
    CNS Drugs 15:59-83. 2001
    ..These studies indicate few differences in medical costs, depression outcomes and health-related quality of life between TCAs and fluoxetine, although fewer fluoxetine-treated patients switched treatment...
  91. ncbi Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial
    Rainer Oberbauer
    Allgemeines Krankenhaus, Wien, Austria
    Transplantation 75:1277-85. 2003
    ..5-point change). CONCLUSIONS: SRL-based therapy with early elimination of CsA results in fewer appearance-related problems, less fatigue, and better vitality compared with continuous treatment with SRL, CsA, and ST...
  92. ncbi Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study
    Carol E Koro
    Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    BMJ 325:243. 2002
    ..2, 0.9 to 5.2) and those taking conventional antipsychotics (1.6, 0.7 to 3.8). CONCLUSION: Olanzapine is associated with a clinically important and significant increased risk of diabetes...
  93. ncbi Assessing meaningful change in quality of life over time: a users' guide for clinicians
    Mirjam A G Sprangers
    Department of Medical Psychology, Academic Medical Center, University of Amsterdam, The Netherlands
    Mayo Clin Proc 77:561-71. 2002
    ....
  94. ncbi Responsiveness and interpretation of a quality of life questionnaire specific to upper gastrointestinal disorders
    Christine de la Loge
    Mapi Values, Lyon, France
    Clin Gastroenterol Hepatol 2:778-86. 2004
    ..CONCLUSIONS: The PAGI-QOL questionnaire is a responsive and clinically relevant instrument for assessing quality of life in patients with upper gastrointestinal disorders...
  95. ncbi Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL
    Christine de la Loge
    Mapi Values, Lyon, France
    Qual Life Res 13:1751-62. 2004
    ....
  96. ncbi Symptom burden among patients with renal cell carcinoma (RCC): content for a symptom index
    Gale Harding
    UBC Center for Health Outcomes Research, Bethesda MD, USA
    Health Qual Life Outcomes 5:34. 2007
    ..Renal cell carcinoma (RCC) has multiple symptoms stemming from disease and treatments. There are few validated scales for evaluating RCC symptoms...
  97. ncbi Patient-reported outcomes assessment in cancer trials: taking stock, moving forward
    Joseph Lipscomb
    Emory University, Atlanta, GA 30322, USA
    J Clin Oncol 25:5133-40. 2007
    ....
  98. ncbi Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial
    Philip J Mease
    Seattle Rheumatology Associates, Seattle, WA 98104, USA
    J Rheumatol 35:20-30. 2008
    ....
  99. ncbi National health preference data: a useful resource for health services research
    Dennis A Revicki
    Med Decis Making 26:310-2. 2006
  100. ncbi Treating depression in predominantly low-income young minority women: a randomized controlled trial
    Jeanne Miranda
    Health Services Research Center, University of California at Los Angeles Neuropsychiatric Institute, CA 90024, USA
    JAMA 290:57-65. 2003
    ..Little is known about the effectiveness of guideline-based care for depression with impoverished minority women, most of whom do not seek care...
  101. ncbi Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine
    Graeme Russ
    The Queen Elizabeth Hospital, Woodville, Woodville South, SA, Australia
    Transpl Int 20:875-83. 2007
    ..SRL-based therapy with early CsA-elimination results in fewer appearance-related problems, less fatigue, greater vitality, and improved general health status and social functioning compared with continuous SRL+CsA+ST treatment...